SGT-003 Gene Therapy Shows Potential in DMD
RA-Specific Physical Activity Resources Provide Guidance but Need Improvement
SECO Keynote to Focus on Novel Technologies for Eye Conditions
Adaptive Deep Brain Stimulation Technology Receives FDA Approval for Parkinson Disease
Disease Burden From Myasthenia Gravis Consistently High
Cetuximab Plus Chemotherapy May Improve Colorectal Cancer Outcomes
Chronic Condition Prevalence Similar in Medicare Advantage, Traditional Medicare Beneficiaries
Future Treatments for AMD Could Mitigate Burden on Patients
House Passes Budget Resolution Cutting Billions From Medicaid Funding
Unpacking Medicare Advantage Criticism With Dr Andrew S. Oseran
A Glimpse Into the Future of Eye Care at SECO 2025
Lung Trauma’s Role in Quality of Life and System Efficiency
Dry Eye Symptom Frequency, Severity Reduced When Using Perfluorohexyloctane
How Insurance Claim Denials Harm Patients’ Health, Finances
Contributor: In a Fast-Growing and Competitive Dual-Eligible Market, Trust Will Be a Critical Differentiator
Dolutegravir/Lamivudine Effective in Adolescents With HIV
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
AMA Survey Highlights Growing Burden of Prior Authorization on Physicians, Patients
Similar Chronic Condition Rates in MA, FFS Beneficiaries Raise Concerns About Overpayments to MA Plans
Health Equity & Access Weekly Roundup: February 24, 2025
Enhancing Patient Access Through Navigation Assistance
Crohn Disease Subtype, Ocular Manifestation Among Risk Factors for EIMs in IBD
Eating Yogurt May Help Reduce Colorectal Cancer Risk
Telemedicine May Reduce Low-Value Testing and Related Costs in Medicare Beneficiaries
Price Caps During Accelerated Approval Would Help Address Financial Toxicity for Patients, Jensen Says
Optimizing Approaches to CAR T, Bispecific Therapies in Myeloma and Lymphoma
Health System Policy Failures Drive Cervical Cancer Disparities in Rural South
Efruxifermin Reverses MASH-Compensated Cirrhosis in Phase 2b SYMMETRY Study
Allogeneic vs Autologous CAR T-Cell Therapy Explained
EU Approves Self-Administered Rozanolixizumab for Myasthenia Gravis